Brief: Ultimovacs Expects Current Cash Resources To Support Ops To H2 2024
Aug 22 (Reuters) - Ultimovacs ASA ULTI.OL :
* EXPECTS THAT CURRENT CASH RESOURCES WILL SUPPORT
OPERATIONS TO
H2 2024
* REVISED TIME FOR INITIUM TOPLINE READOUT HAS MINOR COST
IMPLICATIONS FOR ULTIMOVACS
* OPERATING EXPENSES AMOUNTED TO MNOK 50.6 IN Q2 2023, AND
MNOK
101.4 YTD
Source text for Eikon: ID:nGNEb5MQXM
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant